Wearable patch aims to catch hidden heart rhythms that holter monitors miss

NCT ID NCT07722026

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests whether a wearable patch called MEMO Patch V2 can detect heart rhythm disorders (arrhythmias) more effectively than the standard 24-hour Holter monitor. Adults with symptoms like palpitations or dizziness, or those who have had a stroke of unknown cause, will wear the patch for up to 14 days while also undergoing a 24-hour Holter recording. The study compares how often each device catches an arrhythmia and checks the patch's signal quality, comfort, and skin safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a wearable patch-type ECG monitor called MEMO Patch V2
What this could lead to
If the patch proves more effective, it could offer a more convenient and longer-lasting way to catch intermittent heart rhythm problems that a 24-hour monitor might miss.
What could go wrong
This is a small pilot study, so results may not be definitive. The patch may cause skin irritation or be less comfortable to wear for 14 days, and longer monitoring could pick up harmless irregularities that lead to unnecessary worry.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRYPTOGENIC ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Korea University Anam Hospital

    Seoul, 02841, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.